Prognostic value of immunohistochemical markers RE, RP, Her2/neu in breast cancer in young women

被引：0
|
作者：
Zakirova, L. [1 ]
机构：
[1] Natl Canc Ctr Uzbekistan, Mammol Dept, Tashkent, Uzbekistan
来源：
BREAST | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR81
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Prognostic and predictive value of HER2/neu oncogene in breast cancer
    Masood, S
    Bui, MM
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (02) : 102 - 108
  • [2] HER2:: The Neu prognostic marker for breast cancer
    Tsongalis, GJ
    Ricci, A
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2001, 38 (02) : 167 - 182
  • [3] Prognostic value of immunohistochemical marker HER2/neu in patients resected for gastric cancer stage IIIA
    Levik, E. N.
    ZAPOROZHYE MEDICAL JOURNAL, 2014, (02) : 44 - 47
  • [4] Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study
    Mahyari, Hanifeh Mirtavoos
    Khosravi, Adnan
    Mahyari, Zeinab Mirtavoos
    Monfared, Zahra Esfahani
    Khosravi, Negin
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (11)
  • [5] Prognostic value of HER2 on breast cancer survival
    Katzorke, Nora
    Rack, Brigitte Kathrin
    Haeberle, Lothar
    Neugebauer, Julia Katharina
    Melcher, Carola Anna
    Hagenbeck, Carsten
    Forstbauer, Helmut
    Ulmer, Hans Ulrich
    Soeling, Ulrike
    Kreienberg, Rolf
    Fehm, Tanja N.
    Schneeweiss, Andreas
    Beckmann, Matthias W.
    Fasching, Peter A.
    Janni, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] HER2/neu vaccines in breast cancer
    Khoo, Steven
    Ponniah, Sathibalan
    Peoples, George E.
    WOMENS HEALTH, 2006, 2 (02) : 217 - 223
  • [7] Prognostic markers in breast cancer:: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer
    Taucher, S
    Rudas, M
    Mader, RM
    Gnant, M
    Dubsky, P
    Roka, S
    Bachleitner, T
    Kandioler, D
    Steger, G
    Mittlböck, M
    Jakesz, R
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (1-2) : 26 - 31
  • [8] Analysis of the prognostic value of the shed antigen of HER2/neu in premenopausal breast cancer patiens in the TABLE study
    Luftner, D.
    Pechlivanis, K.
    Geppert, R.
    Stroux, A.
    Possinger, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer
    Wu, YY
    Khan, H
    Chillar, R
    Vadgama, JV
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 14 (06) : 1021 - 1037
  • [10] MicroRNAs as therapeutic and prognostic markers for resistance to therapy in HER2/neu positive breast cancers
    Mathranda, S. A.
    Diwakar, R. B.
    Srihari, S.
    Munirathnam, V.
    Simha, V.
    Anantharamu, S.
    Namani, A.
    Devi, D.
    Korlimarla, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1417 - S1417
12345